The SOURCE Study: Schizophrenia Outcomes-Utilization, Relapse, and Clinical Evaluation: a prospective 2-year observational study of patients with schizophrenia who initiate treatment with injectable risperidone long-acting microspheres (RISPERDAL CONSTA)

Trial Profile

The SOURCE Study: Schizophrenia Outcomes-Utilization, Relapse, and Clinical Evaluation: a prospective 2-year observational study of patients with schizophrenia who initiate treatment with injectable risperidone long-acting microspheres (RISPERDAL CONSTA)

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2014

At a glance

  • Drugs Risperidone (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms SOURCE
  • Sponsors Janssen
  • Most Recent Events

    • 19 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top